SORRENTO THERAPEUTICS INC - ISIN (SRNE)

Historical Holders from Q1 2014 to Q1 2025

Symbol
SRNE on OTC
CUSIP
83587F202
Type / Class
Equity / ISIN
All holders as of December 31, 2024
Q4 2024
13F shares, excl. options
145K
Holdings value
$66.00
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
4
Number of buys
1
Average Value change %
0%
Average buys %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of SORRENTO THERAPEUTICS INC - ISIN (SRNE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 102K $693K +$693K $6.83 1
2024 Q4 145K $66.00 +$33.00 $0.00 4
2024 Q3 79.1K $287 -$225 $0.00 3
2024 Q2 86.8K $826 $0 $0.01 3
2024 Q1 88K $704 -$3.03K $0.01 4
2023 Q4 110K $13.9K +$5.2K $0.12 6
2023 Q3 66.3K $6.33K -$2.1K $0.09 5
2023 Q2 74.1K $26.1K -$1.58M $0.36 8
2023 Q1 4.39M $1.58M -$173M $0.36 31
2022 Q4 204M $180M +$27.3M $0.89 206
2022 Q3 130M $204M +$20.3M $1.57 202
2022 Q2 152M $305M +$48M $2.01 196
2022 Q1 129M $300M +$77M $2.33 209
2021 Q4 90.2M $419M +$25.3M $4.65 205
2021 Q3 84.9M $649M +$65.4M $7.63 207
2021 Q2 76.7M $743M +$4.15M $9.69 195
2021 Q1 76.7M $635M +$1.07M $8.27 218
2020 Q4 73.2M $500M +$43.7M $6.83 195
2020 Q3 72M $803M +$124M $11.15 195
2020 Q2 60.4M $380M +$169M $6.28 168
2020 Q1 33.6M $61.9M +$2.68M $1.84 83
2019 Q4 31.4M $106M +$24.9M $3.38 80
2019 Q3 24.3M $51.9M -$10.5M $2.14 76
2019 Q2 27.9M $74.5M +$15.5M $2.67 74
2019 Q1 22.8M $108M -$37.5M $4.75 78
2018 Q4 30.3M $72.8M -$13.5M $2.40 73
2018 Q3 33.2M $146M +$18.9M $4.40 93
2018 Q2 29.1M $209M +$47M $7.20 90
2018 Q1 23.5M $121M +$62.2M $5.15 68
2017 Q4 10.2M $38.5M +$1.84M $3.80 46
2017 Q3 9.85M $16.8M -$4.96M $1.70 35
2017 Q2 12.5M $24.9M -$4.04M $2.00 44
2017 Q1 13.3M $52.5M +$1.09M $3.95 64
2016 Q4 14.5M $71.1M +$201K $4.90 67
2016 Q3 13M $101M +$1.43M $7.74 59
2016 Q2 12.8M $71.9M -$90.2K $5.60 61
2016 Q1 12.8M $68.7M -$3.62M $5.38 67
2015 Q4 13.1M $114M -$14.6M $8.71 81
2015 Q3 14.8M $124M +$15M $8.39 88
2015 Q2 11.6M $204M +$51.4M $17.62 73
2015 Q1 8.93M $103M +$18.9M $11.56 56
2014 Q4 7.32M $73.7M +$169K $10.07 35
2014 Q3 6.37M $28.8M +$738K $4.52 29
2014 Q2 7.49M $50.6M +$12.3M $6.75 34
2014 Q1 3.73M $47.9M +$13.7M $12.82 28